Full name
INPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
72 - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,1 | 0 | -0 | -101 450,5 |
EBITDA | ||||
Short time liabilities | ||||
Income tax | 0 | 0 | 0 | 0 |
Equity capital | -0,2 | -0,2 | -0,3 | -23,4 |
Operating profit (EBIT) | ||||
Assets | 0,2 | 0,2 | 1 | 431,5 |
Net profit (loss) | -0,1 | 0 | -0 | -101 450,5 |
Cash | ||||
Net income from sale | ||||
Liabilities and provisions for liabilities | 0,4 | 0,4 | 1,3 | 218,9 |
Working assets | 0,2 | 0,2 | 1 | 422,7 |
Basic operational activity income | 1,1 | 1 | 0,6 | -42 |
Depreciation | ||||
% | % | % | p.p. | |
Profitability of capital | ||||
Equity capital to total assets | -99,5 | -108,8 | -25,3 | 83,5 |
Gross profit margin | -5,8 | 0 | -8,3 | -8,3 |
EBITDA Margin | ||||
Days | Days | Days | Days | |
Short term commitment turnover cycle |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane